Network
South East Asia Infectious Disease Clinical Research Network
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 1
1(50.0%)
Phase 4
1(50.0%)
2Total
Phase 1(1)
Phase 4(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT01443806Phase 4Completed
Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand
Role: collaborator
NCT01048073Completed
Non-influenza Etiologies of Acute Respiratory Illness in Southeast Asia
Role: lead
NCT00985582Completed
Antiviral Therapy for Influenza A H1N1
Role: lead
NCT01074736Completed
Host Genetic Susceptibility to Avian Influenza A/H5N1
Role: lead
NCT01049763Phase 1Completed
Open-Label Pharmacokinetic of Oseltamivir in Healthy Obese Thai Adult Subjects
Role: lead
All 5 trials loaded